Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 928
Summary
- Conditions
- Breast Diseases
- Breast Neoplasms
- Neoplasm Metastasis
- Neoplasms by Site
- Skin Diseases
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01917279
- Collaborators
- Hoffmann-La Roche
- Investigators
- Principal Investigator: Binghe Xu, MD, PhD Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Get Well Soon